Rob van Wijk
Rob van Wijk is a postdoctoral researcher at the Institute of Biology Leiden (Animal Sciences and Health) in collaboration with the Leiden Academic Centre for Drug Research (Systems Biomedicine and Pharmacology).
Rob van Wijk performed his PhD research on ‘Translational pharmacokinetics-pharmacodynamics in zebrafish’ at the Leiden Academic Centre for Drug Research (Systems Biomedicine and Pharmacology) in collaboration with the Institute of Biology Leiden (Animal Sciences and Health), under the supervision of prof. dr. Piet Hein van der Graaf, prof. dr. Herman Spaink, and dr. Elke Krekels. This multi-disciplinary project with collaborators from three different research institutes of Leiden University and two international partners, Uppsala University and Dana Farber Cancer Institute, Harvard University, focussed on the quantification of internal drug exposure over time, and drug effect over it concentration for three different drugs (paracetamol, isoniazid, isotretinoin) in the zebrafish and zebrafish larva.
Currently, Rob is appointed as postdoctoral researcher on the recently started IMI project Respiri-NTM, in which novel therapies against nontuberculous mycobacterial infections will be researched utilizing different animal models, including zebrafish.
No relevant ancillary activities